We are honored to inform you that you can now perform the Ninalia Non-Invasive Prenatal Screening Test by Eurofins Biomnis in our laboratories. Eurofins Biomnis is a European leader in the sector of specialized medical pathology, offering a large range of innovative genetic screening tests.
The test is based on the presence of fetal DNA in the maternal blood, which means it bears no risks for the mother or for the baby.
NINALIA enables detection of trisomies 13, 18 and 21, as well as fetal anomalies and disorders.
The advantages of NINALIA prenatal test:
- It requires a single blood sample from the mother
- It bears no risks for the mother or the baby
- It’s available from week 10 of pregnancy
- It has a 99,9% detection rate.
You can choose between two screening options: Ninalia Basic i Ninalia Full.
The Basic package determines the changes in the number of 5 chromosomes and the sex of the child, while the Full package determines the changes in the number of all chromosomes, ie. it provides the screening for all fetal aneuploidies.
Important note: Our laboratories also offer a Panorama prenatal test, which is very reliable and extremely accurate.
Considering that both NINALIA and PANORAMA are very reliable, you can find comparative information that can help you choose the right test for you below.
|Results available in:||7 days||10 days|
|Minimum fetal DNA:||none||4-5 %|
|Weeks of pregnancy:||10.||9.|
|Screening for egg donor:||Yes||Yes|
|Sample:||1 tube of blood||2 tubes of blood|
If you are not sure which test you want to opt for, our geneticists will provide you with all the necessary information.